Schering Stiftung

Prize winner 

Prof. Aviv Regev, Prof. Dr. Stefan Kaufmann, Prof. Dr. Genevieve Almouzni  - Award Ceremony 2021

Prof. Aviv Regev, Prof. Dr. Stefan Kaufmann, Prof. Dr. Genevieve Almouzni - Award Ceremony 2021
Photo: Julia Zimmermann

Prof. Dr. Genevieve Almouzni, Prof. Aviv Regev, Prof. Dr. Stefan Kaufmann   - Award Ceremony 2021Prof. Dr. Genevieve Almouzni, Prof. Aviv Regev, Prof. Dr. Stefan Kaufmann   - Preisverleihung 2021

Prof. Dr. Genevieve Almouzni, Prof. Aviv Regev, Prof. Dr. Stefan Kaufmann - Award Ceremony 2021Prof. Dr. Genevieve Almouzni, Prof. Aviv Regev, Prof. Dr. Stefan Kaufmann - Preisverleihung 2021

Prof. Aviv Regev, PhD

Prof. Aviv Regev, PhD
Photo: Casey Atkins

Prof. Regev and a team member

Prof. Regev and a team member
Photo: Foundation for the National Institutes of Health

Aviv Regev

Ernst Schering Prize 2021

Aviv Regev

Ernst Schering Prize 2021

Professor Aviv Regev, PhD, is Executive Vice President and Global Head of Genentech Research and Early Development at the biotechnology company Genentech, a member of the Roche Group. Prior to Genentech, Regev served as founding director of the Klarman Cell Observatory at the Broad Institute, Professor of Biology at MIT, and Investigator of the Howard Hughes Medical Institute. She is a founding co-chair of the Human Cell Atlas. Aviv Regev has pioneered the development of foundational experimental and computational methods in single-cell genomics and is a leader in deciphering molecular circuits that govern cells, tissues, and organs in health and disease. Among many honors, she is an elected member of the National Academy of Sciences and the National Academy of Medicine in the United States.

For her outstanding research, Prof. Aviv Regev, PhD, is awarded the 2021 Ernst Schering Prize. A seven-member jury composed of international scientists selected Regev’s research from among 27 nominations.

Aviv Regev was nominated for the Ernst Schering Prize by Professor Geneviève Almouzni, PhD, Honorary Director and Head of the Chromatin Dynamics team at the Research Center of the Institut Curie, Paris. Geneviève Almouzni, who will lead a conversation with Aviv Regev about her research at the award ceremony, said: “Aviv Regev is one of the leading scientists of her generation. Her energy and her curiosity are infectious, and she inspires younger generations thanks to her leadership and mentoring skills. Her contributions to the field of single-cell genomics, including the establishment and inspiration of the international Human Cell Atlas community, make her an ideal choice for the Ernst Schering Prize.”


Read more

Side events 

Lecture to high-school students: The Human Cell Atlas. Google Maps for the Human Body

September 08, 2021
Aviv Regev

Schulfarm Insel Scharfenberg, Berlin-Tegel (not open to the public)

Podcast – Episode 6

Dialogue — October 19, 2021

Aviv Regev and Judith Feucht, this year’s recipients of our science prizes, talk, among other things, about how basic research can be successfully translated into clinical application.

Learn more

Aviv Regev: Public Scientific Lecture

Lecture — September 08, 2021

This year's Ernst Schering Prize laureate, Aviv Regev, will present her latest research results to a scientific audience.

Learn more

Award Ceremony 2021

Award ceremony — September 07, 2021

Schering Stiftung awards Ernst Schering Prize to the computional biologist Aviv Regev. The physician and junior research group leader Judtih Feucht will be awarded with the Friedmund Neumann Prize.

Learn more

Ernst Schering Prize Lecture

Lecture — September 07, 2021

Aviv Regev will give a keynote lecture on the occasion of the award of the Ernst Schering Prize.

Learn more


Public Lecture

at MPI for Melecular Genetics

Download File


Stefan Kaufmann is founding director and director of the Department of Immunology of the Max Planck Institute for Infection Biology in Berlin and Professor for Microbiology and Immunology at the Charité University Hospital in Berlin. He received his Ph.D. in biology (“summa cum laude”) from Johannes Gutenberg University in Mainz and completed his habilitation in the field of immunology and microbiology at the Freie Universität Berlin in 1981. From 1987 until 1991, he was Professor for Medical Microbiology and Immunology, and from 1991 until 1998, he was Full Professor for Immunology at Ulm University.


Pico Caroni has been a senior group leader at the Friedrich Miescher Institute (FMI) for Biomedical Research and a professor of neurobiology at the Biozentrum/The Center for Molecular Life Sciences at the University of Basel since 1995. He studied biochemistry at ETH Zürich and subsequently worked on regeneration in the central nervous system in Martin Schwab’s lab at the Brain Research Institute of the University of Zurich. Since 1989, Caroni has been a researcher at the FMI – first as a junior group leader – studying the plasticity of defined neuronal circuits and systems. He is interested not only in the fundamentals of learning and memory but also in the impact of gene mutations on the circuits and the resulting mental disorders.


Britta Eickholt has been Professor of Molecular and Cellular Biochemistry at the Charité - Universitätsmedizin Berlin since 2011. She received her doctorate in 1998 at Guy's Hospital in London. In 2001, she received a lectureship at King's College London and started her own research group at the MRC Center for Developmental Neurobiology. She was appointed Professor of Molecular Neurobiology at King's College in 2010, before her move to Berlin in 2011. Her research focusses on the signaling mechanisms that regulate dynamic processes of the cytoskeleton in neuronal cells.


Carl-Henrik Heldin has, since 1992, been professor in Molecular Cell Biology at Uppsala University, Sweden. Between 1986 and 2017, he was the Branch Director of the Ludwig Institute for Cancer Research in Uppsala. Professor Heldin is the chair of the Boards of the Nobel Foundation, the Science for Life Laboratory, and the European Molecular Biology Organization. His research interest is related to the mechanisms of signal transduction by growth regulatory factors, as well as their normal function and role in disease. An important goal is to explore the possible clinical utility of signal transduction antagonists.


Petra Knaus received her Ph.D. at the Center for Molecular Biology in Heidelberg in 1991. As a Research Fellow and Associate, she did her Postdoctoral Training at the Whitehead Institute for Biomedical Research, USA, until 1996. After her return to Germany, she was Junior Group Leader at the Biocenter in Würzburg. There she established her own lab with a focus on BMP receptor biology and signal transduction. In 2004 she became Full Professor for Biochemistry – Signaltransduction at the Institute for Chemistry and Biochemistry at the Freie Universität Berlin. In 2010 she received a W3 Professorship for Biochemistry – Signaltransduction and Regeneration at the Freie Universität Berlin and Charité. The interest of the Knaus lab is to understand the molecular mechanism of BMP signal transduction, and to identify common and distinct mechanistic concepts in different cell and tissue environments.


Hartmut Michel studied Biochemistry at the Universities of Tübingen and Munich. He completed his doctoral degree at the University of Würzburg in 1977 and habilitated in 1988 at the University of Munich. Since 1987 he is Director at the Max Planck Institute for Biophysics at Frankfurt/Main, where he leads the Department for Molecular Membrane Biology. In 1988, Hartmut Michel was awarded the Nobel Prize for Chemistry, together with Johannes Deisenhöfer and Robert Huber, for their investigation of the molecular structure of the photosynthesis reaction center in the rhodopseudomonas viridis bacterium.


Martin Oestreich has been Professor of Organic Chemistry (Synthesis & Catalysis) at TU Berlin since 2011. His appoitment was supported through an Einstein professorship by the Einstein Foundation Berlin. He studied chemistry at the Universities of Düsseldorf, Manchester, and Marburg (1991–1996) and received his doctoral degree at the University of Münster (1996–1999). After a postdoctoral stint at the University of California at Irvine (1999–2001), he completed his habilitation at the University of Freiburg (2001–2005). Martin Oestreich was Professor of Organic Chemistry at the University of Münster from 2006 until 2011. Visiting professorships took him to Cardiff (2005), Canberra (2010), and Kyoto (2018). His research interest range from homogeneous catalysis with main-group elements to elucidation of reaction mechanisms.


You might also be interested in

September 05, 2023

Matthias Tschöp

Ernst Schering Prize 2023

September 29, 2022

Gisbert Schneider

Ernst Schering Prize 2022

September 30, 2020

Jens Claus Brüning

Ernst Schering Prize 2020

September 24, 2019

Patrick Cramer

Ernst Schering Prize 2019

September 26, 2018

Bonnie L. Bassler

Ernst Schering Prize 2018


Contact & social networks

Schering Stiftung

Unter den Linden 32-34
10117 Berlin

Telefon: +49.30.20 62 29 62

Opening hours
Project space

Thursday to Monday: 1 pm - 7 pm
Saturday to Sunday: 11 am - 7 pm
free entrance

Follow us!

Follow us on our social media channels to find out the latest developments!

facebook Youtube Instagram